Bank Hapoalim Bm Red Hill Biopharma Ltd. Transaction History

Bank Hapoalim Bm

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 05, 2018	SELL	$4.58 - $10.81 $622,934 - $1.47 Million	-136,012 Closed	0 $0
Q3 2017 Nov 07, 2017	SELL	$8.25 - $10.81 $327,087 - $428,584	-39,647 Reduced 22.57%	136,012 $1.47 Million
Q2 2017 Aug 11, 2017	BUY	N/A	175,659	175,659 $1.51 Million

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

Stay updated on Bank Hapoalim Bm with notifications on news.